Table 2 Logistic analysis of the relation between NDUFAF6 expression and clinical variables in BC patients
Characteristics | Total (N) | Odds ratio (OR) | P value |
|---|---|---|---|
T stage (T2&T3&T4 vs. T1) | 1080 | 0.939 (0.714–1.234) | 0.651 |
N stage (N1&N2&N3 vs. N0) | 1064 | 1.199 (0.943–1.526) | 0.139 |
M stage (M1 vs. M0) | 922 | 2.302 (0.915–6.551) | 0.090 |
Pathologic stage (Stage II&Stage III&Stage IV vs. Stage I) | 1060 | 0.991 (0.719–1.366) | 0.957 |
Race (Black or African American vs. Asian) | 241 | 0.469 (0.254–0.849) | 0.014 |
Age (> 60 vs. <  = 60) | 1083 | 1.229 (0.967–1.563) | 0.092 |
Histological type (Infiltrating Lobular Carcinoma vs. Infiltrating Ductal Carcinoma) | 977 | 0.591 (0.432–0.807) |  < 0.001 |
PR status (Positive vs. Negative) | 1030 | 1.835 (1.412–2.391) |  < 0.001 |
ER status (Positive vs. Negative) | 1033 | 2.549 (1.887–3.469) |  < 0.001 |
HER2 status (Positive vs. Negative) | 715 | 1.247 (0.874–1.782) | 0.224 |
PAM50 (LumA&LumB&Her2 vs. Basal) | 1043 | 2.300 (1.669–3.194) |  < 0.001 |
Menopause status (Post vs. Pre) | 932 | 1.281 (0.951–1.729) | 0.104 |
Anatomic neoplasm subdivisions (Right vs. Left) | 1083 | 0.872 (0.687–1.107) | 0.261 |
Radiation_therapy (Yes vs. No) | 987 | 0.993 (0.772–1.277) | 0.957 |